Current Chronic Obstructive Pulmonary Disease Treatment Status in Asia: A Position Statement of the Asian Pacific Society of Respirology.
作者信息
Choi Joon Young, Milne Stephen, Yunus Faisal, Rhee Chin Kook, Matsunaga Kazuto
机构信息
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
University of British Columbia Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
出版信息
Tuberc Respir Dis (Seoul). 2022 Jul;85(3):279-282. doi: 10.4046/trd.2022.0020. Epub 2022 May 2.
Abstract
摘要
相似文献
1
Current Chronic Obstructive Pulmonary Disease Treatment Status in Asia: A Position Statement of the Asian Pacific Society of Respirology.亚洲慢性阻塞性肺疾病的当前治疗现状：亚太呼吸学会立场声明
Tuberc Respir Dis (Seoul). 2022 Jul;85(3):279-282. doi: 10.4046/trd.2022.0020. Epub 2022 May 2.
2
Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology.亚洲慢性阻塞性肺疾病管理：亚太呼吸学会立场声明。
Respirology. 2019 Oct;24(10):1018-1025. doi: 10.1111/resp.13633. Epub 2019 Jul 5.
3
APSR statement on asthma management (APSR AM-1997): workshop summary. Asian Pacific Society of Respirology.亚太呼吸学会关于哮喘管理的声明（APSR AM - 1997）：研讨会总结。亚太呼吸学会
Respirology. 1998 Jun;3(2):63-8. doi: 10.1111/j.1440-1843.1998.tb00098.x.
4
Respirology and the Asia-Pacific Century.呼吸病学与亚太世纪
Respirology. 2017 Jan;22(1):7-8. doi: 10.1111/resp.12953. Epub 2016 Nov 27.
5
Air Pollution in the Asia-Pacific Region. A Joint Asian Pacific Society of Respirology/American Thoracic Society Perspective.亚太地区的空气污染。亚太呼吸学会/美国胸科学会联合观点。
Am J Respir Crit Care Med. 2019 Mar 15;199(6):693-700. doi: 10.1164/rccm.201804-0673PP.
6
Air pollution in the Asia-Pacific Region: A Joint Asian Pacific Society of Respirology/American Thoracic Society perspective (Republication).亚太地区的空气污染：亚太呼吸学会/美国胸科学会联合观点（再版）
Respirology. 2019 May;24(5):484-491. doi: 10.1111/resp.13531. Epub 2019 Mar 28.
7
How to write research papers and grants: 2011 Asian Pacific Society for Respirology Annual Scientific Meeting Postgraduate Session.如何撰写研究论文和申请书：2011 年亚太呼吸学会年会研究生专场。
Respirology. 2012 Jul;17(5):792-801. doi: 10.1111/j.1440-1843.2012.02175.x.
8
Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective.慢性阻塞性肺疾病全球倡议：慢性阻塞性肺疾病诊断、管理和预防策略——亚太视角
Respirology. 2005 Jan;10(1):9-17. doi: 10.1111/j.1440-1843.2005.00692.x.
9
Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement.比拉斯汀在过敏性鼻炎和荨麻疹治疗中的作用：亚太地区共识声明
Asia Pac Allergy. 2016 Jan;6(1):56-66. doi: 10.5415/apallergy.2016.6.1.56. Epub 2016 Jan 27.
10
Nurturing respiratory clinician-scientists-An important priority in the Asia-Pacific and for the Asia-Pacific Society of Respirology (APSR).培养呼吸科临床科学家——这是亚太地区以及亚太呼吸学会（APSR）的一项重要优先事项。
Respirology. 2022 Jul;27(7):490-492. doi: 10.1111/resp.14271. Epub 2022 Apr 26.
引用本文的文献
1
Pathophysiology, clinical manifestation, and treatment of tuberculosis-associated chronic obstructive pulmonary disease: a narrative review.结核相关慢性阻塞性肺疾病的病理生理学、临床表现及治疗：一项叙述性综述
Ewha Med J. 2025 Apr;48(2):e24. doi: 10.12771/emj.2025.00059. Epub 2025 Mar 19.
2
Effects of Triple Therapy on the Clinical Course of Non-Eosinophilic COPD Groups B.三联疗法对非嗜酸性粒细胞性慢性阻塞性肺疾病B组临床病程的影响
J Korean Med Sci. 2025 Jul 21;40(28):e147. doi: 10.3346/jkms.2025.40.e147.
3
Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study.比较 COPD 治疗起始时使用 LAMA 与 LABA/ICS 的成本和医疗资源利用（HCRU）：来自 CITRUS（比较噻托溴铵和 ICS/LABA 在韩国真实世界使用中的发生率）研究的结果。
Int J Chron Obstruct Pulmon Dis. 2024 Jul 16;19:1661-1671. doi: 10.2147/COPD.S448492. eCollection 2024.
4
Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.韩国患者慢性阻塞性肺疾病加重的临床特征和频率：来自 KOCOSS 队列 2012-2021 年的研究结果。
J Korean Med Sci. 2024 May 20;39(19):e164. doi: 10.3346/jkms.2024.39.e164.
5
Stepwise management of COPD: What is next after bronchodilation?COPD 的阶梯式管理：支气管扩张治疗之后接下来该怎么做？
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231208630. doi: 10.1177/17534666231208630.
6
Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015-2019.近年来快速老龄化社会中慢性阻塞性肺疾病的流行情况及相关因素：韩国 2015-2019 年国家健康和营养调查。
J Korean Med Sci. 2023 Apr 10;38(14):e108. doi: 10.3346/jkms.2023.38.e108.
本文引用的文献
1
Clinical Characteristics of Chronic Obstructive Pulmonary Disease in Female Patients: Findings from a KOCOSS Cohort.慢性阻塞性肺疾病女性患者的临床特征：来自 KOCOSS 队列的研究结果。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 22;15:2217-2224. doi: 10.2147/COPD.S269579. eCollection 2020.
2
Use of medicines and health services for chronic obstructive pulmonary disease among a cohort of Australians over 50 years.50岁以上澳大利亚人群中慢性阻塞性肺疾病的药物使用及医疗服务利用情况
Int J Chron Obstruct Pulmon Dis. 2018 Oct 4;13:3085-3093. doi: 10.2147/COPD.S172495. eCollection 2018.
3
Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction.体重指数对轻度至中度气流受限患者病情加重及医疗费用的影响。
Int J Chron Obstruct Pulmon Dis. 2018 Jul 27;13:2261-2269. doi: 10.2147/COPD.S163000. eCollection 2018.
4
Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: a multicenter cross-sectional CAP study.使用改良的医学研究委员会量表对慢性阻塞性肺疾病急性加重风险进行分层：一项多中心横断面社区获得性肺炎研究
Respir Investig. 2015 Mar;53(2):82-5. doi: 10.1016/j.resinv.2014.10.006. Epub 2014 Nov 18.
5
The global burden of chronic respiratory disease in adults.成人慢性呼吸道疾病的全球负担。
Int J Tuberc Lung Dis. 2015 Jan;19(1):10-20. doi: 10.5588/ijtld.14.0446.
6
COPD in India: Iceberg or volcano?印度的 COPD：冰山一角还是火山爆发？
J Thorac Dis. 2012 Jun 1;4(3):298-309. doi: 10.3978/j.issn.2072-1439.2012.03.15.
7
Association between lung function and exacerbation frequency in patients with COPD.COPD 患者肺功能与加重频率的相关性。
Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826.
8
Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.1996年至2007年加拿大安大略省慢性阻塞性肺疾病的患病率、发病率和死亡率趋势：一项基于人群的研究。
Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17.
9
Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.中国慢性阻塞性肺疾病的患病率：一项基于人群的大型调查。
Am J Respir Crit Care Med. 2007 Oct 15;176(8):753-60. doi: 10.1164/rccm.200612-1749OC. Epub 2007 Jun 15.
Zotero 插件